Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study.

Transl Cancer Res · 2019 · PMC8799233 · PMID 35116944

Europe PMC DOI

hedged sentence

0.0990

closest p · 2.0× alpha

0.0990

boldest claim

The sentences

showed a trendP=0.099so close (0.05 < p ≤ 0.1)

The median ALB level in the DEB-TACE group showed a trend of being higher than that in the cTACE group (P=0.099).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.